TMCnet News
BUYINS.NET: Market Maker Surveillance Report. ENMD, EGHT, EXEL, GU, WEST, NADVF, Winning Stocks With Lowest Price Friction For Tuesday, June 7th 2011(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 2796 companies with "abnormal" market making, 2442 companies with positive Friction Factors and 2263 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. ENTREMED INC (NASDAQ:ENMD), 8X8 INC (NASDAQ:EGHT), EXELIXIS INC (NASDAQ:EXEL), GUSHAN ENVIRONMENTAL ENE-ADR (NYSE:GU), AKEENA SOLAR INC (NASDAQ:WEST), NATURALLY ADVANCED TECHNOLOG (OTCBB:NADVF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . Market Maker Friction Factor is shown in the chart below: Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction ENMD $0.600 15.79% 229,465 59.63% 154,019 40.03% 75,446 1,257 EGHT $0.600 19.05% 2,074,145 57.45% 1,531,601 42.42% 542,544 9,042 EXEL $1.120 12.89% 3,359,078 57.20% 2,366,457 40.30% 992,621 8,863 GU $0.630 29.30% 156,637 42.25% 111,794 30.16% 44,843 712 WEST $0.280 14.77% 3,345,165 51.37% 3,158,762 48.51% 186,403 6,657 NADVF $0.402 12.35% 73,615 38.84% 51,850 27.36% 21,765 542 Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent. For example, the chart above shows ENMD with a dollar gain Tuesday of $0.60000 and a Friction Factor of 1,257 shares. That means that it only took 1,257 more shares of buying than selling to move ENMD higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal. ENTREMED INC (NASDAQ:ENMD) - EntreMed, Inc., a clinical-stage pharmaceutical company, engages in developing therapeutics for the treatment of cancer and inflammatory diseases. It is developing primarily ENMD-2076, a selective angiogenic kinase inhibitor for the treatment of cancer. ENMD-2076 is in Phase I studies in advanced cancers, multiple myeloma, and leukemia. The companys other drug candidates include MKC-1, an oral cell-cycle inhibitor with activity against the mTOR pathway, which has completed Phase II clinical trials for cancer; ENMD-1198, an orally-active antimitotic agent that has completed a Phase I clinical trial in advanced cancers; and Panzem (2ME2), an orally active compound, which is under Phase I clinical trial for the treatment of rheumatoid arthritis. EntreMed, Inc. was founded in 1991 and is headquartered in Rockville, Maryland. 8X8 INC (NASDAQ:EGHT) - 8x8, Inc. develops and markets telecommunications services for Internet protocol (IP), telephony, and video applications, as well as provides Web-based conferencing and unified communications services. The company offers the 8x8 VoIP voice and video digital phone service, 8x8 Virtual Office hosted private branch exchange (PBX) service, 8x8 Complete Contact Center service, 8x8 Trunking service, 8x8 Hosted Key System service, 8x8 MobileTalk service, 8x8 Virtual Meeting Web conferencing service, and the 8x8 Virtual Office Pro unified communications solution. The 8x8 Virtual Office suite of business phone services offers high definition audio-enhanced communications services that eliminate the need for traditional telecommunications services and business phone systems. The 8x8 Virtual Office solution replaces an on-premise PBX telephone system with a hosted, Internet-based business phone service that is delivered over a managed or unmanaged Internet connection. The company also sells pre-programmed IP telephones with speakerphones and a display screen in conjunction with its Virtual Office service plans, which enable its business customers to access additional Virtual Office features through on-screen phone menus. Its 8x8 Virtual Office Pro unified communications solution bundles the 8x8 Virtual Office hosted PBX phone service with other businesses software communications services, such as Web conferencing, call recording and archiving, Internet fax, chat, voicemail, presence management, and a mobile iPhone/iPad extension. 8x8, Inc. also offers 8x8 Managed Hosting and Cloud-Based Computing solutions to business customers through its subsidiary, Central Host, Inc. The company markets its services under the 8x8 brand in the United States and internationally. As of March 31, 2010, it had approximately 20,000 business customers who use its services as their primary business telephone system. 8x8, Inc. was founded in 1987 and is headquartered in Sunnyvale, California. EXELIXIS INC (NASDAQ:EXEL) - Exelixis, Inc. engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer, metabolic, and cardiovascular disorders. The company's compounds primarily target multiple receptor tyrosine kinases simultaneously. Its product candidates include XL184, a Phase 3 clinical trial compound that inhibits MET, RET, and VEGFR2, which drive tumor growth and vascularization, as well as Phase 1b/2 clinical trials compounds, including XL147 that targets phosphoinositide-3 kinase (PI3K); and XL765, which targets PI3K and mTOR, kinases in the PI3K signaling pathway. The company also has various compounds in phase 1 clinical trials, including XL518, a small molecule inhibitor of the MEK; XL228, which targets insulin-like growth factor type 1 receptor, an RTK in a range of human tumors; XL139 that targets Hedgehog; XL413, a small molecule inhibitor of the serine-threonine kinase CDC7; and XL888, a synthetic inhibitor of HSP90, a chaperone protein that promotes the activity and stability of a range of regulatory proteins, including kinases. In addition, its preclinical and clinical development stage products that are out-licensed to third parties for the development and commercialization include XL880, a phase 2 inhibitor of MET and VEGFR2; XL281, a phase 1 product that targets RAF, a cytoplasmic serine/threonine kinase; XL652 and XL041, a phase 1 product for liver X receptors, which modulate genes involved in regulation of lipid and cholesterol homeostasis; XL550, a non-steroidal mineralocorticoid receptor; and FXR Program that targets Farnesoid X Receptor, a bile acid receptor. Exelixis, Inc. has collaborations with Bristol-Myers Squibb Company; Genentech, Inc.; GlaxoSmithKline; Pfizer; and Daiichi Sankyo Company Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California. GUSHAN ENVIRONMENTAL ENE-ADR (NYSE:GU) - Gushan Environmental Energy Limited, through its subsidiaries, produces biodiesel and its by-products. Its biodiesel is used to produce chemical products, primarily produced from various feed stocks, such as vegetable oil, animal fat, and recycled cooking oil; to fuel a range of diesel engines in trucks, mass transit vehicles, marine vessels, and generators; and as fatty acid methyl ester in the chemical industry. The companys biodiesel by-products include glycerine, plant asphalt, erucic acid, and erucic amide, which are used in various commercial applications in the food, pharmaceutical, and manufacturing industries. The company serves direct users, including marine vessel operators and chemical companies; petroleum wholesalers, such as local subsidiaries of state-owned enterprises or privately owned companies; and individual retail gas stations in the Peoples Republic of China. Gushan Environmental Energy Limited was founded in 2001 and is based in Fuzhou City, the Peoples Republic of China. AKEENA SOLAR INC (NASDAQ:WEST) - Akeena Solar, Inc., doing business as Westinghouse Solar, engages in the design, manufacture, integration, and installation of solar power systems under the Westinghouse name. It offers its solar power systems for residential and commercial customers. The company also designs and distributes solar panels with integrated micro inverters (called as AC solar panels). Westinghouse Solar sells its AC solar panels to solar installers, trade workers, and do-it-yourself customers through distribution partnerships, dealer network, and retail outlets. It has a strategic partnership with Real Goods Solar, whereby Real Goods Solar operates as an authorized dealer for westinghouse solar power systems for sale to its customers in California and Colorado markets. The company was founded in 2001 and is headquartered in Los Gatos, California. NATURALLY ADVANCED TECHNOLOG (OTCBB:NADVF) - Naturally Advanced Technologies Inc. engages in the development and execution of CRAILAR and CRAiLEX bast fiber processing technologies for use in the textile, pulping, composite, and plastics industries. The company focuses on providing textile, composite, biomass, and pulping solutions through the process of industrial hemp and other bast fiber crops. It involves in developing technologies for processing CRAiLEX advanced materials, which are cellulose-based fibers for use in pulp and paper, bio plastics, and performance apparel industries; and CRAiLAR organic fibers for applications in the apparel and textile industries. The company was formerly known as Hemptown Clothing Inc. and changed its name to Naturally Advanced Technologies Inc. in March 2006. Naturally Advanced Technologies was founded in 1998 and is based in Vancouver, Canada. About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports. Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks. Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups. Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks. GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time. DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures. Contact: BUYINS.NET Thomas Ronk 800-715-9999 [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). (c) 2011 M2 COMMUNICATIONS |